Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01009112 · ClinicalTrials.gov registry record · NA
Treating Insomnia & Nightmares After Trauma: Impact on Symptoms & Quality of Life
A NA study, sponsored by University of California, San Diego.
- Completed
- Registry status
- NA
- Development phase
- 45
- Enrollment target
NCT01009112: Completed NA study, sponsored by University of California, San Diego.
NCT01009112 is a NA study that has completed, run by University of California, San Diego. The registered enrollment target is 45 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01009112, a NA study, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
Study Summary
Exposure to trauma, especially when it manifests as Posttraumatic Stress Disorder (PTSD), results in numerous negative consequences for patients, families, and society. Some of the most frequent, disturbing, and treatment resistant symptoms of PTSD are nightmares and insomnia. This study will examine whether treatments specifically targeted at those sleep disorders can improve clinical outcomes and increase health-related quality of life in individuals recently exposed to war-related trauma. Hypotheses are that treating nightmares and insomnia will improve both nighttime and daytime symptoms of PTSD, as well as quality of life.
Interventions
- BEHAVIORAL PTSD + IRT/CBT-I
- BEHAVIORAL PTSD + Supportive Care Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2010-01 |
| Est. Completion | 2012-11 |
| Phase | NA |
What the finished NCT01009112 record still lists
NCT01009112 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which PTSD + IRT/CBT-I is the first listed.
NCT01009112 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01009112 about?
NCT01009112 is a clinical study titled "Treating Insomnia & Nightmares After Trauma: Impact on Symptoms & Quality of Life". Exposure to trauma, especially when it manifests as Posttraumatic Stress Disorder (PTSD), results in numerous negative consequences for patients, families, and society. Some of the most frequent, disturbing, and treatment resistant symptoms of PTSD are nightmares and insomnia. This study will examin...
What is the current status of trial NCT01009112?
This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2010-01. Estimated completion is 2012-11.
What interventions are being tested in trial NCT01009112?
The interventions under investigation include: PTSD + IRT/CBT-I (BEHAVIORAL), PTSD + Supportive Care Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT01009112?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01009112's enrollment target sits among peer trials
45 1411th of 2000 higher than 578 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia